MyAverix Finance
US · Healthcare
Kailera Therapeutics, Inc. Common Stock (KLRA)
Biotechnology
Kailera Therapeutics, Inc. Common Stock (KLRA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for KLRA
Kailera Therapeutics, Inc. Common Stock (KLRA) — FAQ
What is KLRA's P/E ratio?
The price-to-earnings (P/E) ratio for Kailera Therapeutics, Inc. Common Stock (KLRA) is 25.00 (data as of 2026-05-23).
Does Kailera Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Kailera Therapeutics, Inc. Common Stock (KLRA). Check the MyAverix Finance app for the latest dividend data.
What sector is Kailera Therapeutics, Inc. Common Stock in?
Kailera Therapeutics, Inc. Common Stock (KLRA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is KLRA listed on?
KLRA is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.